Strides Pharma Science : and Mylan to release General Claims Escrow on Agila transaction to receive ~US$ 42 Mn immediately from General Claims Escrow

December 19, 2018
BSE Limited	The National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers,	Exchange Plaza , Bandra‐Kurla Complex
Dalal Street, Mumbai - 400 001	Bandra (E) Mumbai ‐ 400 051
Scrip code: 532531	Scrip code: STAR
Dear Sirs,

Strides and Mylan to release General Claims Escrow on Agila transaction Strides to receive ~US$ 42 Mn immediately from General Claims Escrow

As announced on December 05, 2013, the Company and its wholly owned subsidiary, Strides Pharma Asia Pte Ltd ("Subsidiary") completed the sale to Mylan Laboratories Limited and Mylan Institutional Inc. of Agila Specialties Private Limited and Agila Specialties Global Pte Limited respectively, pursuant to Sale and Purchase Agreements effective as of February 27, 2013 ("SPAs") on December 04, 2013.

Mylan made claims against the General Claims Escrow which included a third‐party claim that was subject to resolution under international arbitration. The claims in that arbitration were rejected in their entirety. Strides will receive ~ US$ 42 Mn towards full and final release of the General Claims Escrow immediately.

You are requested to take the same on record.

For Strides Pharma Science Limited

Manjula Ramamurthy

Company Secretary

Strides Pharma Science Limited

(Formerly Strides Shasun Limited)

CIN: L24230MH1990PLC057062

Corp Off: Strides House, Bilekahalli, Bannerghatta Road, Bangalore - 560 076, India

Tel: [phone] Fax: [phone]

Regd Off: 201, Devavrata, Sector 17, Vashi, Navi Mumbai - 400 703, India

Tel: [phone] / 3199 Fax: [phone]; www.strides.com